These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 20730719)

  • 21. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The value of natriuretic peptides NT-pro-BNP and BNP for the assessment of left-ventricular volume and function. A prospective study of 150 patients].
    Pfister R; Scholz M; Wielckens K; Erdmann E; Schneider CA
    Dtsch Med Wochenschr; 2002 Dec; 127(49):2605-9. PubMed ID: 12469271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma brain natriuretic peptide level after radiofrequency catheter ablation of paroxysmal, persistent, and permanent atrial fibrillation.
    Yamada T; Murakami Y; Okada T; Yoshida N; Toyama J; Yoshida Y; Tsuboi N; Inden Y; Hirai M; Murohara T
    Europace; 2007 Sep; 9(9):770-4. PubMed ID: 17670784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinant factors of plasma B-type natriuretic peptide levels in patients with persistent nonvalvular atrial fibrillation and preserved left ventricular systolic function.
    Baba O; Izuhara M; Kadota S; Mitsuoka H; Shioji K; Uegaito T; Mutsuo S; Matsuda M
    J Cardiol; 2009 Dec; 54(3):402-8. PubMed ID: 19944315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].
    Tarantini L; Cioffi G; Di Lenarda A; Valle R; Pulignano G; Del Sindaco D; Frigo G; Soravia G; Tessier R; Catania G
    G Ital Cardiol (Rome); 2008 Dec; 9(12):835-43. PubMed ID: 19119693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction: a comparison to systolic dysfunction and normal ventricular function.
    Cha YM; Wokhlu A; Asirvatham SJ; Shen WK; Friedman PA; Munger TM; Oh JK; Monahan KH; Haroldson JM; Hodge DO; Herges RM; Hammill SC; Packer DL
    Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):724-32. PubMed ID: 21747059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in NT-proBNP levels in patients with atrial fibrillation related to heart failure].
    Pokorná V; Jurkovicová O; Kaluzay J; Stecová A; Pont'uch P
    Vnitr Lek; 2010 Aug; 56(8):788-94. PubMed ID: 20845610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients.
    Post F; Weilemann LS; Messow CM; Sinning C; Münzel T
    Crit Care Med; 2008 Nov; 36(11):3030-7. PubMed ID: 18824903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BNP as a marker of diastolic dysfunction in the general population: Importance of left ventricular hypertrophy.
    Lukowicz TV; Fischer M; Hense HW; Döring A; Stritzke J; Riegger G; Schunkert H; Luchner A;
    Eur J Heart Fail; 2005 Jun; 7(4):525-31. PubMed ID: 15921790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In patients with severe systolic dysfunction, only brain natriuretic peptide is related to diastolic restrictive pattern.
    Catuzzo B; Ciancamerla F; Bobbio M; Longo M; Trevi GP
    J Card Fail; 2003 Aug; 9(4):303-10. PubMed ID: 13680551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
    J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of time course and predicting factors of progression of paroxysmal or persistent atrial fibrillation to permanent atrial fibrillation.
    DE Sisti A; Leclercq JF; Halimi F; Fiorello P; Bertrand C; Attuel P
    Pacing Clin Electrophysiol; 2014 Mar; 37(3):345-55. PubMed ID: 24236932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Doppler-derived indexes and B-type natriuretic peptide in prediction of paroxysmal atrial fibrillation in essential hypertension: a prospective study.
    Badran HM; Eid MA; Michael A
    Echocardiography; 2007 Oct; 24(9):911-22. PubMed ID: 17894569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Asanin M; Stankovic S; Mrdovic I; Matic D; Savic L; Majkic-Singh N; Ostojic M; Vasiljevic Z
    Peptides; 2012 May; 35(1):74-7. PubMed ID: 22421508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain natriuretic peptide levels as a predictor for new atrial fibrillation during hospitalization in patients with acute ischemic stroke.
    Shibazaki K; Kimura K; Fujii S; Sakai K; Iguchi Y
    Am J Cardiol; 2012 May; 109(9):1303-7. PubMed ID: 22341921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative plasma B-type natriuretic peptide (BNP) identifies abnormal transthoracic echocardiography in elderly patients with traumatic hip fracture.
    Pili-Floury S; Ginet M; Saunier L; Besch G; Bartholin F; Chopard R; Boillot A; Mebazaa A; Samain E
    Injury; 2012 Jun; 43(6):811-6. PubMed ID: 22029947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B-type natriuretic peptide level after sinus rhythm restoration in patients with persistent atrial fibrillation - clinical significance.
    Wozakowska-Kapłon B; Bartkowiak R; Grabowska U; Janiszewska G
    Kardiol Pol; 2010 Jul; 68(7):781-6. PubMed ID: 20648436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction.
    Ling LH; Kistler PM; Ellims AH; Iles LM; Lee G; Hughes GL; Kalman JM; Kaye DM; Taylor AJ
    J Am Coll Cardiol; 2012 Dec; 60(23):2402-8. PubMed ID: 23141493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction.
    Letsas KP; Filippatos GS; Pappas LK; Mihas CC; Markou V; Alexanian IP; Efremidis M; Sideris A; Maisel AS; Kardaras F
    Clin Res Cardiol; 2009 Feb; 98(2):101-6. PubMed ID: 18975023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.